Cognex Corporation (NASDAQ:CGNX – Get Free Report) EVP Sheila Marie Dipalma sold 2,002 shares of the business’s stock in a transaction on Friday, September 5th. The stock was sold at an average price of $45.00, for a total value of $90,090.00. Following the completion of the sale, the executive vice president directly owned 8,582 shares in the company, valued at $386,190. This represents a 18.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.
Sheila Marie Dipalma also recently made the following trade(s):
- On Monday, September 8th, Sheila Marie Dipalma sold 2,000 shares of Cognex stock. The stock was sold at an average price of $45.03, for a total value of $90,060.00.
Cognex Stock Performance
CGNX opened at $44.40 on Thursday. Cognex Corporation has a one year low of $22.67 and a one year high of $45.23. The stock’s fifty day moving average is $39.33 and its 200-day moving average is $32.88. The company has a market capitalization of $7.45 billion, a PE ratio of 62.54 and a beta of 1.50.
Cognex Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were paid a $0.08 dividend. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Thursday, August 14th. Cognex’s payout ratio is currently 45.07%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of CGNX. Nordea Investment Management AB grew its holdings in shares of Cognex by 148.5% during the second quarter. Nordea Investment Management AB now owns 7,075,772 shares of the scientific and technical instruments company’s stock valued at $223,594,000 after buying an additional 4,228,729 shares in the last quarter. Mackenzie Financial Corp grew its stake in Cognex by 126.2% in the first quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company’s stock valued at $137,510,000 after purchasing an additional 2,571,457 shares in the last quarter. AQR Capital Management LLC grew its stake in Cognex by 18,810.9% in the second quarter. AQR Capital Management LLC now owns 1,794,649 shares of the scientific and technical instruments company’s stock valued at $56,657,000 after purchasing an additional 1,785,159 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its stake in Cognex by 32.0% in the first quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company’s stock valued at $181,436,000 after purchasing an additional 1,474,832 shares in the last quarter. Finally, Mawer Investment Management Ltd. purchased a new position in Cognex in the second quarter valued at about $45,723,000. Hedge funds and other institutional investors own 88.12% of the company’s stock.
Analyst Ratings Changes
CGNX has been the topic of a number of recent analyst reports. Robert W. Baird boosted their target price on Cognex from $30.00 to $32.00 and gave the stock a “neutral” rating in a research report on Monday, June 16th. Citigroup reaffirmed a “neutral” rating and set a $37.00 target price (up from $30.00) on shares of Cognex in a research report on Monday, July 14th. The Goldman Sachs Group boosted their target price on Cognex from $29.00 to $32.00 and gave the stock a “sell” rating in a research report on Thursday, June 12th. UBS Group boosted their target price on Cognex from $53.00 to $58.00 and gave the stock a “buy” rating in a research report on Friday, August 1st. Finally, DA Davidson boosted their target price on Cognex from $32.00 to $35.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $42.31.
Cognex Company Profile
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Read More
- Five stocks we like better than Cognex
- What is the Euro STOXX 50 Index?
- Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion
- Dividend Capture Strategy: What You Need to Know
- Despite Pullback, Rocket Lab Still Looks Primed for a Breakout
- Investing In Preferred Stock vs. Common Stock
- Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.